Product Details

Dexamethasone + Pheniramine for Injection BP delivers a high-quality sterile combination therapy that meets British Pharmacopoeia (BP) standards. This fixed-dose injectable combination manages acute allergic and inflammatory conditions, combining corticosteroid and antihistamine action in a single sterile solution for I.M./I.V. use.

The injection combines:

• Dexamethasone, a corticosteroid that reduces inflammation and suppresses acute allergic and hypersensitivity responses by suppressing the body’s inflammatory pathways, and
• Pheniramine Maleate, an antihistamine that relieves allergic symptoms by blocking histamine H1 receptors, reducing itching, swelling, and allergic reactions.

Doctors commonly prescribe this combination for acute allergic reactions, anaphylaxis (as adjunct therapy), angioedema, and other conditions requiring rapid anti-allergic and anti-inflammatory intervention. Hospitals, clinics, and emergency care settings rely on this formulation for its consistent quality and dependable therapeutic results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• BP-standard compliant injectable combination therapy
• Manages acute allergic reactions and inflammatory conditions
• Delivers combined corticosteroid and antihistamine action
• Contains Dexamethasone 4 mg + Pheniramine Maleate 22.75 mg per mL
• For I.M./I.V. use, suited for rapid clinical response
• Maintains a high-purity, sterile formulation
• Suits hospital, emergency care, and clinical use